MedTrace Logo

Pronostic Factors in Elderly Patients Admitted to the Intensive Care Unit for Aneurysmal Subarachnoid Hemorrhage

NCT07508683 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2026-04-02

No results posted yet for this study

Summary

Subarachnoid hemorrhage (SAH) represents a significant proportion of hemorrhagic strokes. Severe SAH in elderly patients is associated with poorer outcomes compared to younger cohorts. Better characterization of both short- and long -term prognosis in these patients is necessary to facilitate medical decision-making in the intensive care unit (ICU)

Primary Objective:

The primary objective is to identify prognostic factors associated with poor functional outcome or death at 6 months (± 2 months) in elderly patients admitted to the ICU for SAH.

Secondary Objectives:

To evaluate in-hospital mortality among elderly patients admitted to the ICU for SAH.

To describe the causes of in-hospital death (brain death, withholding/withdrawal of life-sustaining treatment \[WOLST\], other medico-surgical causes) in elderly patients admitted to the ICU for SAH.

To describe the care trajectory following hospital discharge for elderly patients admitted to the ICU for SAH.

To evaluate the mean length of stay in the ICU and in the hospital (acute care) for elderly patients admitted to the ICU for SAH.

To identify prognostic factors associated with poor functional outcome or death at 1 year in elderly patients admitted to the ICU for SAH.

Conditions

  • Subarachnoid Hemorrhage, Aneurysmal

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Viviane MARTIN, Chief of Research Departement · CHRU NANCY, DRCI

  • Elodie JEANBERT, Methodologist, Statistician · CHRU NANCY, DRCI

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2026-11-30
Completion
2027-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07508683 on ClinicalTrials.gov